In Reply In their letter regarding our Viewpoint,1 Philpotts and Durand call attention to 3 studies. First, they take issue with the reference in our article to the study by Sharpe et al,2 an observational study that evaluated changes in recall among women undergoing breast cancer screening after the introduction of digital breast tomosynthesis. The study did not find a significantly lower recall rate with digital breast tomosynthesis among women 70 years and older compared with 2-dimensional mammography. Philpotts and Durand cite a critique of that study,3 but the critique expressed concern that the analysis had overestimated effectiveness of digital breast tomosynthesis, not underestimated it. In addition, the critique likely reflected a misunderstanding of the analysis rather than an actual error in the original publication.3
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Richman IB, Gross CP. Digital Breast Tomosynthesis for Women Older Than 70 Years—Reply. JAMA Intern Med. 2019;179(6):853–854. doi:10.1001/jamainternmed.2019.0957
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: